Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hisun Pharmaceutical Exports Fluvastatin To Europe

This article was originally published in PharmAsia News

Executive Summary

Hisun Pharmaceutical shipped 900,000 fluvastatin capsules to Europe in November. It is the first China enterprise to cooperate with an overseas partner to enter the EU under its branded pharmaceutical formulation. Hisun collaborates with a German drug manufacturer to apply for European pharmaceutical certifications for its fluvastatin formulation and received approval in August. Even though the fluvastatin export will not contribute substantially to the firm's profit in the short term, it paves the way for Hisun's strategic shift from the production of active pharmaceutical ingredients to higher value-added co-development of APIs and formulations. (Click here for more - Chinese language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067586

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel